Shares of Abbott Laboratories rose after the company reported Q1 results largely in line with expectations. BTIG analyst Marie Thibault reiterated a Buy rating and a $131 price target, noting that while the company's sales growth outlook reflects lower expectations in some segments, the overall Q1 performance was solid and the sales outlook leaves room for upside. Management also lowered its 2026 adjusted earnings projection but expects sales growth to accelerate in the second half of the year.

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Franklin BSP Realty Trust (NYSE:FBRT), alleging the company made false and misleading statements regarding its prospects and ability to maintain its dividend. Investors who purchased FBRT securities between November 5, 2024, and February 11, 2026, and suffered losses are encouraged to contact the firm before April 27, 2026, to apply for lead plaintiff status. The lawsuit claims that the company's statements about its business lacked a reasonable basis, leading to investor damages.

RTX (NYSE:RTX) is set to report its Q1 2026 earnings on April 21, with significant geopolitical developments, particularly the Iran War, expected to drive defense demand. The company's execution credibility will be under scrutiny, as it must prove it can convert a massive backlog ($268B) into earnings to justify its premium 40 P/E valuation and meet analyst price targets of $215.66. Critical factors to watch include Raytheon's munitions output growth, clarity on tariff impacts, and the performance of Pratt & Whitney's GTF fleet management program.

Axon Enterprise (AXON) significantly beat Q4 EPS estimates by 34% with $2.15 against a consensus of $1.60, driven by 39% year-over-year revenue growth and strong bookings. Despite a 34% year-to-date stock price drop, analysts see an 80% upside with a mean target of $708, supported by its $14.4 billion contracted backlog and accelerating platform expansion. The company also introduced a strong 2026 revenue growth outlook and launched new AI products, although potential data privacy risks remain a key concern.

This article reviews the top four most trusted and licensed online casinos in Michigan: BetMGM Casino, DraftKings Casino, FanDuel Casino, and Caesars Palace Online Casino. It highlights their licensing, safety standards, bonuses, and player experience, all regulated by the Michigan Gaming Control Board. The review emphasizes that trust, regulation, game variety, bonus quality, payout speed, mobile experience, and customer support are key factors in evaluating these platforms.

Palo Alto Networks Inc. (PANW) disclosed $590,000 in lobbying activity for Q1 2026, focusing on cybersecurity threats and funding for federal, state, local, and critical infrastructure networks, as well as AI and quantum computing policies. The article also details recent congressional stock trading, insider trading, hedge fund activity, analyst ratings, and price targets for PANW stock.

A recent Lobbying Disclosure Act filing revealed that THE BOEING COMPANY disclosed $80,000 in lobbying expenditures for Q1 2026, focusing on issues such as FY26 Appropriations and NDAA. The article also details recent congressional stock trading, insider trading activity, and hedge fund movements related to BA stock, alongside current analyst ratings and price targets.

PHILLIPS 66 (PSX) has disclosed $80,000 in lobbying expenditures for Q1 2026, focusing on issues related to shareholder proposals and proxy advisors. Recent insider trading shows more sales than purchases, while institutional investors have mixed activity. Wall Street analysts have issued both buy and sell ratings, with a median price target of $177.0.

BMO Capital has reduced its price target for CMS Energy (NYSE:CMS) to $85 from $86, while maintaining an Outperform rating. This adjustment follows the Michigan Public Service Commission Staff's initial brief in CMS Energy’s gas rate case, recommending a revenue requirement of $183 million, which is about 76% of the company's requested $240 million. Despite the price target cut, BMO Capital views the staff's position as constructive.

BMO Capital has reaffirmed its Outperform rating on Travelers Companies Inc. (NYSE:TRV) shares, anticipating a 1% to 3% rise in consensus estimates due to expected first-quarter 2026 reserve releases. While pricing deceleration in the commercial insurance market is expected to lead to a higher underlying loss ratio, the firm maintains a positive outlook. This reaffirmation follows Travelers' strong Q1 2026 financial results, which surpassed earnings and revenue expectations, yet other analysts like BofA Securities have maintained an Underperform rating citing missed earnings and negative premium growth.